A delegation from UMass Chan Medical School, Massachusetts’s first and only public academic health sciences center, recently visited Dubai Health, solidifying a new chapter in healthcare collaboration between the two organizations. The visit, marked by the signing of a Memorandum of Understanding (MOU), granted the delegation the opportunity to gain insight into Dubai’s first integrated academic health system, laying the groundwork for a productive partnership.

Inspired by UMass Chan’s reputation for impact through collaborative endeavour and aspiration to change the course of the history of disease, the partnership reflects a shared vision between the two academic health systems to advance health. Under the agreement, UMass Chan and Dubai Health will establish mutually beneficial research projects to improve patient care, create an exchange framework for learners between the two academic institutions, and drive transformative advancements for public health, both locally and globally.

Led by Michael F. Collins, MD, Senior Vice President for Health Sciences and Chancellor at UMass Chan, the visit also included an opportunity for Dubai Health learners to gain insight into elective and residency program opportunities at UMass Chan.

Commenting on the partnership, Professor Alawi Alsheikh-Ali, Deputy CEO and Chief Academic Officer of Dubai Health, and Provost of MBRU, stated, “This collaboration presents an exciting opportunity to combine the strengths of two academic health organizations. By pooling our resources, capabilities, and expertise, we are well-positioned to advance the frontier of medical knowledge that better serves our communities. The visit has been incredibly productive, laying the foundation for meaningful collaboration anchored in our shared purpose of advancing health for humanity.”

Michael F. Collins, MD, Senior Vice President for Health Sciences and Chancellor of UMass Chan commented “It is a privilege, along with a group of senior colleagues, to learn more about the breadth and depth of activity taking place at Dubai Health and to forge closer relationships with its leadership. The signing of an MOU between our respective institutions is an exciting development and provides UMass Chan and Dubai Health with a framework from which to pursue meaningful collaborations and exchanges, by partnering, we do hope to advance together on behalf of the communities that we serve.”

The UMass Chan delegation included Michael F. Collins, MD, Senior Vice President for Health Sciences and Chancellor; Terence R. Flotte, MD, Provost, Dean, and Executive Deputy Chancellor; David D. McManus, MD, Chair, Department of Medicine; Anne Larkin, MD, Associate Professor of Surgery, Vice Provost, and Senior Associate Dean for Educational Affairs; Lisa Colombo, DNP, MHA, RN, Executive Vice Chancellor and CEO, ForHealth Consulting; Rebekah Diamond, JD, Executive Director, Business Strategy & Operational Excellence, ForHealth Consulting; Brendan Chisholm, Vice Chancellor of Management, Chief of Staff, Office of the Chancellor.

Building on Dubai Health's vision to advance health for humanity, The Royal Marsden NHS Foundation Trust has been selected to support the clinical and operational development of the Hamdan Bin Rashid Cancer Hospital (HBRCH), Dubai's first integrated, comprehensive cancer hospital.

The partnership marks a significant step forward in enhancing the standard of cancer treatment in Dubai, where specialized and compassionate care will be accessible in one place.

As one of the world's leading hospitals dedicated to cancer diagnosis, treatment, research, and education, The Royal Marsden will work with Dubai Health to establish a model of excellence in comprehensive cancer care at HBRCH. Their renowned expertise will be leveraged across several key areas, including developing specialist, evidence-based models of care, early diagnosis, and treatment pathways that guide patients through every step of their journey.

The HBRCH program of care will span from early detection to treatment, recovery, and post-treatment support. A key focus of this partnership will be building a world-class, specialized team of cancer care professionals. This will involve creating a robust workforce plan, developing advanced training programmers, and fostering a culture of continuous learning. Additionally, the partnership will seek to establish a cancer research program, fostering a culture of discovering transformative advancements in cancer care.

Her Excellency Dr. Raja Easa Al Gurg, Chairperson of Al Jalila Foundation Board of Directors and Member of Dubai Health Board of Directors, said, “We are honored to join forces with The Royal Marsden, a global leader in cancer research and treatment. Their renowned expertise and approach to care perfectly complement the care, learning, discovery, and giving missions of our integrated academic health system. Through this partnership, we are honoring the collective generosity of our esteemed donors whose unwavering support to Al Jalila Foundation is fulfilling our vision for the Hamdan Bin Rashid Cancer Hospital to become a beacon of hope for patients and families facing a cancer diagnosis. It propels us closer to achieving the Dubai Social Agenda 33 goal of delivering a world-class healthcare system of the highest efficiency and quality."

Dame Cally Palmer, Chief Executive, The Royal Marsden, said: “I am delighted that The Royal Marsden has been chosen to work in partnership with Dubai Health to advance the clinical development of the Hamdan Bin Rashid Cancer Hospital. This is an excellent opportunity for international collaboration, and to adapt the best practices in state-of-the-art healthcare provision and establish the structure upon which this advanced, innovative and future-looking hospital can be based.”

“At The Royal Marsden our integrated NHS and Private Care model, underpinned by a research and academic infrastructure, delivers outstanding personalized care for our patients. Through a staged program of work, The Royal Marsden and Dubai Health aim to establish a long-term strategic partnership that will not only develop a new hospital but support specialized cancer care across the wider healthcare system in Dubai,” she added.

Set to open in 2026, the HBRCH will offer a groundbreaking model of care under Dubai Health. As part of Dubai’s first integrated academic health system, the comprehensive cancer hospital will create multidisciplinary teams to spearhead a transformative shift in care delivery. Research and clinical trials will be at the heart of the hospital, fostering a culture of discovery and accelerating progress in cancer care. With 50 clinics, 30 research areas, 60 infusion rooms, and 116 inpatient beds spread across a sprawling 56,000-square-metre campus, the hospital is positioned to become a beacon of hope for cancer patients in the UAE and the region.

Dubai Health announced a strategic partnership between Al Jalila Children’s Hospital and the Children’s National Hospital in Washington, D.C., aiming to bring about a significant shift in pediatric healthcare.

The announcement follows a series of mutual visits. In the latest such visit, Dr. Amer Sharif, CEO of Dubai Health, led a delegation to the headquarters of Children’s National Hospital. The visit included a tour of the Sheikh Zayed Institute for Pediatric Surgical Innovation and the Children’s National Research Institute, during which both sides discussed ways to further strengthen their strategic collaboration.

Partnership of 8 years

For over eight years, the partnership has focused on technology, specialized pediatric training, and improving healthcare quality for children. The expanded collaboration will now include several key areas, such as advanced systems development, data management, and increased access to pediatric care through innovations such as remote patient monitoring. Additionally, comprehensive and specialized training programs will be launched for healthcare professionals at Al Jalila Children’s Hospital. Starting next year, a cohort of medical professionals will receive advanced training, integrating best practices and innovative care models from Children’s National Hospital to further elevate pediatric care standards.

“Together, we are deepening our shared commitment to advancing pediatric healthcare,” said Michelle Riley-Brown, President and CEO of Children's National Hospital. “This collaboration is about more than just exchanging knowledge – it's about building sustainable, innovative solutions that will improve health outcomes for children, both in the UAE and globally. We want to ensure every child receives the highest quality of treatment, no matter where they live.”

Leadership’s support highlighted

Dr. Amer Sharif, CEO of Dubai Health, said: “We are honored to visit the Children’s National Hospital in Washington, D.C. and the Sheikh Zayed Institute for Pediatric Surgical Innovation, affiliated with the hospital, where the support of our wise leadership in fostering innovation and scientific research is evident both locally and internationally. I extend my deepest gratitude to the government of the UAE for providing us the opportunity to strengthen ties with the most prestigious health and scientific institutions in the world. This has opened new avenues for collaboration and created new opportunities for effective, impactful partnerships.

“Strengthening our partnership with Children’s National Hospital, one of the world’s leading pediatric institutions, underscores our commitment to advancing children’s health through our integrated academic health system. The collaboration aligns with the Dubai Social Agenda 33 and is aimed at building an efficient healthcare ecosystem that meets the highest global standards. It also reinforces Dubai’s position as a global leader in healthcare, medical education, and scientific research.

“We extend our gratitude to Children’s National Hospital for their invaluable collaboration in strengthening this partnership. Through this alliance, we aim to enhance children’s care with an evidence-based approach, aligning with Dubai Health’s core value of putting the patient first throughout the healthcare journey,” he added.

Dr. Mohammed Al Awadhi, Deputy CEO of Al Jalila Children’s Hospital and Latifa Hospital, added: “The strengthening of our partnership with Children’s National Hospital will continue our work to elevate the standard of care for children in Dubai and beyond. Specifically, it will enable us to enhance operational efficiency, particularly in pediatric subspecialties, ensuring the best possible care for every child.

“We will also work closely with the Children’s National Hospital on leadership training, quality improvement, intensive care practices, and other areas to enhance the efficiency of pediatric care at Al Jalila Children’s Hospital.”

In 2018, Al Jalila Children’s Hospital signed a health information technology (IT) agreement with Children's National Hospital. Leveraging its extensive expertise and resources, Children’s National Hospital served as a strategic advisor, helping Al Jalila Children’s Hospital expand its health IT capabilities to deliver the highest quality of care for children. Building on this collaboration, another agreement in 2022 focused on education and consulting services, resulting in Children’s National Hospital conducting specialized training for cardiac ICU nurses, significantly enhancing Al Jalila Children’s Hospital’s clinical capabilities.